SILVERIO, ANGELO
 Distribuzione geografica
Continente #
AS - Asia 4.968
NA - Nord America 2.660
EU - Europa 986
SA - Sud America 319
AF - Africa 63
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.004
Nazione #
HK - Hong Kong 3.302
US - Stati Uniti d'America 2.593
SG - Singapore 782
CN - Cina 284
VN - Vietnam 274
BR - Brasile 247
RU - Federazione Russa 213
IT - Italia 210
DE - Germania 169
FR - Francia 81
FI - Finlandia 60
IN - India 57
IE - Irlanda 47
TR - Turchia 39
KR - Corea 38
UA - Ucraina 37
GB - Regno Unito 36
BD - Bangladesh 35
CA - Canada 32
SE - Svezia 27
NL - Olanda 26
JP - Giappone 25
MX - Messico 25
AR - Argentina 23
PL - Polonia 21
ID - Indonesia 20
ES - Italia 19
IQ - Iraq 19
ZA - Sudafrica 18
CO - Colombia 15
CZ - Repubblica Ceca 13
EC - Ecuador 13
SA - Arabia Saudita 13
PK - Pakistan 11
MA - Marocco 10
PH - Filippine 9
UZ - Uzbekistan 9
CL - Cile 8
KE - Kenya 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
LU - Lussemburgo 7
EG - Egitto 6
LT - Lituania 6
VE - Venezuela 6
KZ - Kazakistan 5
NP - Nepal 5
DZ - Algeria 4
LB - Libano 4
PS - Palestinian Territory 4
AL - Albania 3
AU - Australia 3
EU - Europa 3
JO - Giordania 3
PA - Panama 3
RO - Romania 3
TN - Tunisia 3
AT - Austria 2
AZ - Azerbaigian 2
BH - Bahrain 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KW - Kuwait 2
LY - Libia 2
PY - Paraguay 2
SN - Senegal 2
UY - Uruguay 2
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
CV - Capo Verde 1
CY - Cipro 1
ET - Etiopia 1
FJ - Figi 1
GD - Grenada 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LV - Lettonia 1
NE - Niger 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SO - Somalia 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 9.004
Città #
Hong Kong 3.299
Singapore 426
San Jose 407
Ashburn 252
Ann Arbor 201
Dallas 195
Chandler 180
Munich 101
Princeton 101
Wilmington 94
Council Bluffs 85
Ho Chi Minh City 84
Los Angeles 73
Houston 72
Beijing 70
Lauterbourg 69
Woodbridge 54
Hanoi 53
The Dalles 49
Boardman 48
Jacksonville 48
New York 48
Dublin 45
Turku 44
Dong Ket 43
Santa Clara 29
São Paulo 29
Moscow 27
Izmir 22
Denver 21
Tokyo 21
Montreal 20
Frankfurt am Main 19
Salerno 18
Warsaw 18
Andover 17
Naples 17
Orem 17
Amsterdam 15
Mestre 15
Rome 15
Washington 15
Nanjing 14
Phoenix 14
Chennai 12
Johannesburg 12
Mexico City 12
Brno 11
Da Nang 11
Falls Church 11
Atlanta 10
Chicago 10
Haiphong 10
Stockholm 10
Nuremberg 9
Poplar 9
Rio de Janeiro 9
Tashkent 9
Belo Horizonte 8
Boston 8
Brooklyn 8
Pellezzano 8
Seattle 8
Brasília 7
Columbus 7
Fairfield 7
Helsinki 7
Milan 7
Querétaro 7
Turin 7
Würselen 7
Ankara 6
Cairo 6
Manchester 6
Nairobi 6
New Delhi 6
San Francisco 6
Seoul 6
Toronto 6
Baghdad 5
Buffalo 5
Dammam 5
Dudelange 5
Guayaquil 5
London 5
Mumbai 5
Nanchang 5
Norwalk 5
Paris 5
Redwood City 5
Campinas 4
Changsha 4
Charlotte 4
City of London 4
Dearborn 4
Düsseldorf 4
Guarulhos 4
Ha Long 4
Hải Dương 4
Istanbul 4
Totale 6.888
Nome #
Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome and Left Ventricular Outflow Tract Obstruction 933
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions 527
Predictors of Recurrent Ischemic Events in Patients With ST-Segment Elevation Myocardial Infarction 421
Infective endocarditis and diabetes mellitus: Results from a single-center study from 1994 to 2017 388
A novel MIR-371a-5p-mediated pathway, leading to BAG3 upregulation in cardiomyocytes in response to epinephrine, is lost in Takotsubo cardiomyopathy 323
COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives 281
Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease 238
Anterior mitral valve aneurysm perforation in a patient with preexisting aortic regurgitation 215
Polymorphisms of the antiapoptotic protein bag3 may play a role in the pathogenesis of tako-tsubo cardiomyopathy 192
Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia 177
Partial clip detachment and posterior mitral leaflet perforation after mitraclip implantation 168
Aortic dissection in patients with autosomal dominant polycystic kidney disease: a series of two cases and a review of the literature 160
Global longitudinal strain predicts outcome after MitraClip implantation for secondary mitral regurgitation 153
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvement 153
Valve-in-Valve Transcatheter Aortic Valve Replacement: From Pre-Procedural Planning to Procedural Scenarios and Possible Complications 152
Thrombus straddling a patent foramen ovale 142
Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment 142
Arterial Hypertension in Patients with Takotsubo Syndrome: Prevalence, Long-Term Outcome, and Secondary Preventive Strategies. A Report from the Takotsubo Italian Network Register 140
Contemporary imaging in takotsubo syndrome 135
Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19 130
Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation 125
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets 122
Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 120
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction 115
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome 114
Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention 111
Clinical conditions and echocardiographic parameters associated with mortality in COVID-19 110
Prognostic Implications of Right Ventricular Function and Pulmonary Pressures Assessed by Echocardiography in Hospitalized Patients with COVID-19 104
Risk stratification using the CHA2DS2-VASc score in Takotsubo syndrome: Data from the Takotsubo Italian network 102
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction 102
Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes 99
Transcatheter repair of functional mitral regurgitation in heart failure patients: A meta-analysis of 23 studies on mitraclip implantation 99
Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients 95
Big Health Data and Cardiovascular Diseases: A Challenge for Research, an Opportunity for Clinical Care 94
Prevalence and Predictors of Out-of-Target LDL Cholesterol 1 to 3 Years After Myocardial Infarction. A Subanalysis From the EYESHOT Post-MI Registry 92
Safety and feasibility of balloon aortic valvuloplasty in non-TAVI centers: The “BAV for life” experience 92
From Planning to Practice: Impact of Achieved Proximal Sealing Zone in Endovascular Aneurysm Repair (EVAR) 91
Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect? 90
Anti-Apoptotic BAG3 Gene in Tako-Tsubo Cardiomyopathy 89
Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes 87
A peculiar etiology of acute heart failure: adrenergic myocarditis 83
Artificial intelligence in cardiovascular prevention: new ways will open new doors 81
Biomarkers predict in-hospital major adverse cardiac events in covid-19 patients: A multicenter international study 76
Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies 75
Machine learning-based prediction of in-hospital death for patients with takotsubo syndrome: The InterTAK-ML model 74
Novel targets and strategies addressing residual cardiovascular risk in post-acute coronary syndromes patients 73
Reply 68
Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study-The ISNEP Study 68
Clinical and Echocardiographic Features of Patients With Infective Endocarditis and Bicuspid Aortic Valve According to Echocardiographic Definition of Valve Morphology 67
Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach-Where Do We Stand? 67
Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging 67
Dynamic Left Intraventricular Obstruction Phenotype in Takotsubo Syndrome 65
Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome 59
Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during coronavirus disease 2019 pandemic: a case report 59
Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma 58
Impella in Takotsubo syndrome complicated by left ventricular outflow tract obstruction and severe mitral regurgitation 56
ICARUS score for predicting peri-procedural bleeding in patients undergoing percutaneous coronary intervention with cangrelor 55
Prognostic Impact of Mitral Regurgitation Before and After Transcatheter Aortic Valve Replacement in Patients With Severe Low-Flow, Low-Gradient Aortic Stenosis 53
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 51
Cardiovascular Mortality in Takotsubo Syndrome 51
Prevalence and Prognostic Significance of Right Ventricular Dysfunction in Patients With Severe Low‐Flow, Low‐Gradient Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement 50
How the COAPT trial affected the selection of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair: insights from the GIOTTO registry 48
Editorial: Advances in Percutaneous Coronary Intervention 46
Comparison of mortality in primary and secondary Takotsubo cardiomyopathy with severe left ventricular dysfunction: reply 46
Response to: Correspondence on 'Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome' by John E Madias 41
Invasive and Non-invasive Assessment of Non-culprit Coronary Lesions in Patients with ST-segment Elevation Myocardial Infarction 40
null 40
Echocardiographic tools for prognostic stratification in transthyretin cardiac amyloidosis: a new arrow in the quiver 36
Competing Risks of Cardiac and Noncardiac Mortality in Patients With Secondary Mitral Regurgitation Undergoing Transcatheter Edge‐to‐Edge Repair 33
Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients 33
Response to: Correspondence on 'Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome' by Chang et al 31
Predictors of thromboembolic events in Takotsubo syndrome: reply 29
Consolidating the value of fondaparinux for current treatment of non-ST-elevation acute coronary syndromes 27
Dual Antiplatelet Therapy with 3rd Generation P2Y12 Inhibitors in STEMI Patients: Impact of Body Mass Index on Loading Dose–Response 24
Clinical Outcome of Hospitalized COVID-19 Patients with History of Atrial Fibrillation 24
Loeffler’s Endocarditis: An Integrated Multimodality Approach 24
Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients 19
Understanding changes in central nervous system function after transcatheter aortic valve replacement 16
Totale 9.136
Categoria #
all - tutte 26.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 0 9 48
2021/2022184 0 0 0 2 11 8 6 13 24 18 25 77
2022/2023413 29 50 17 48 71 72 2 32 65 5 16 6
2023/2024353 11 36 35 14 33 67 6 9 0 17 13 112
2024/2025984 24 4 30 34 23 73 199 42 130 79 196 150
2025/20266.410 977 1.476 1.365 330 620 191 544 141 276 425 65 0
Totale 9.136